We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Measurement of Compound-Induced Cytotoxicity with Roche’s xCELLigence Real-Time Cell Analysis System
News

Measurement of Compound-Induced Cytotoxicity with Roche’s xCELLigence Real-Time Cell Analysis System

Measurement of Compound-Induced Cytotoxicity with Roche’s xCELLigence Real-Time Cell Analysis System
News

Measurement of Compound-Induced Cytotoxicity with Roche’s xCELLigence Real-Time Cell Analysis System

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Measurement of Compound-Induced Cytotoxicity with Roche’s xCELLigence Real-Time Cell Analysis System"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents.

Viability and cytotoxicity assays are routinely used to determine how various treatments potentially perturb cell homeostasis leading to decreased viability and increased cytotoxicity. Many agents used for cancer therapeutics modulate the intricate balance between cell proliferation and cell death. The ultimate aim of cancer therapy is to reduce or eliminate cancerous cells in the body, thus shifting the balance by either increasing cell death or decreasing cell proliferation.

In a recent study of Ning Ke and Yama Abassi of ACEA Bioscience in San Diego, Roche’s xCELLigence System had been used for studying cell viability and cell death when testing various cytotoxic compounds.  Real-time impedance-based cell analyzers, such as the RTCA SP Instrument and E-Plate 96, could identify the onset of cytotoxicity using continuous impedance-based monitoring of cell viability, pinpointing when maximal effects occur.

Furthermore, the instrument identified the best time point, i.e., when CI values are at their lowest, for conducting functional endpoint assays that examine cell fate transitions, such as apoptosis and cell cycling, in greater detail. The xCELLigence System also proved to be suitable for identifying culture wells with inappropriate cell numbers at the beginning of the assay, thus minimizing the role of cell seeding and culture plate edge artifacts during data analysis.

The xCELLigence System allows for real-time, label-free and dynamic monitoring of cellular phenotypic changes by measuring electrical impedance. The system measures impedance using interdigitated microelectrodes integrated into the bottom of each well of the tissue culture E-Plates 96. Impedance measurements are displayed as Cell Index (CI) values, providing quantitative information about the biological status of the cells, including cell number, cell viability and cell morphology.

Impedance-based monitoring of cell viability correlates to cell number and MTT-based readout. The kinetic aspect of impedance-based cell viability measurements provides the necessary temporal information, for instance, when compounds of interest are used to induce cytotoxic effects.

In particular, the xCELLigence System is ideal for pinpointing optimum time points, i.e., when cytotoxic compounds achieve their maximum effect, as indicated by the lowest CI values in cytotoxicity and cell death assays.
Advertisement